Sign in

CIK 0001678660

  • Non-accelerated filer
  • Smaller reporting company

Prelude Therapeutics Inc

Sign in to watch
Ticker
PRLD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811384762
Phone
+1 302-467-1280
Business address
175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
Former names
Prelude Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-10-05 Mauro David J Chief Medical Officer Sale −7,803 $31.30 $244K 1,289
2021-10-05 Mauro David J Chief Medical Officer Sale −1,289 $32.06 $41K 0
2021-10-05 Mauro David J Chief Medical Officer Exercise or conversion · Employee Stock Option (Right to Buy) −15,000 137,610
2021-09-07 Mauro David J Chief Medical Officer Exercise or conversion +15,000 $1.89 $28K 15,000
2021-09-07 Mauro David J Chief Medical Officer Sale −7,487 $35.91 $269K 7,513
2021-09-07 Mauro David J Chief Medical Officer Sale −2,873 $36.92 $106K 4,640
2021-09-07 Mauro David J Chief Medical Officer Sale −4,640 $37.79 $175K 0
2021-09-07 Mauro David J Chief Medical Officer Exercise or conversion · Employee Stock Option (Right to Buy) −15,000 167,610
2021-09-02 Pierce Christopher EVP and Chief of Business Oper Exercise or conversion +17,000 $12.85 $218K 20,750
2021-09-02 Pierce Christopher EVP and Chief of Business Oper Sale −3,343 $40.29 $135K 17,407
2021-09-02 Pierce Christopher EVP and Chief of Business Oper Sale −6,727 $41.52 $279K 10,680
2021-09-02 Pierce Christopher EVP and Chief of Business Oper Sale −6,930 $42.50 $295K 3,750
2021-09-02 Pierce Christopher EVP and Chief of Business Oper Exercise or conversion · Employee Stock Option (right to buy) −17,000 207,796
2021-08-27 Scherle Peggy Chief Scientific Officer Exercise or conversion +6,014 $1.43 $9K 178,934
2021-08-27 Scherle Peggy Chief Scientific Officer Sale −2,700 $35.32 $95K 176,234
2021-08-27 Scherle Peggy Chief Scientific Officer Sale −2,707 $36.23 $98K 173,527
2021-08-27 Scherle Peggy Chief Scientific Officer Sale −607 $37.08 $23K 172,920
2021-08-27 Scherle Peggy Chief Scientific Officer Exercise or conversion · Employee Stock Option (Right to Buy) −6,014 27,018
2021-08-26 Scherle Peggy Chief Scientific Officer Exercise or conversion +1,700 $1.43 $2K 174,620
2021-08-26 Scherle Peggy Chief Scientific Officer Sale −1,700 $35.19 $60K 172,920

Page 9 of 19 · 369 trades